Marrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation Therapy

Abstract
Patients with homozygous beta-thalassemia, who have a good prognosis during treatment with conventional therapy, appear to have an especially high probability of hematologic cure with bone marrow transplantation, although the morbidity and mortality associated with such treatment are not established.